SSRI Selection and Management

Introduction to SSRI Properties

• Paroxetine is the most sedating SSRI, while fluoxetine and sertraline are the least sedating SSRIs available, according to the American Academy of Family Physicians 1
• Paroxetine has the highest sedation potential among SSRIs, contributing to its sedating properties, as described by the American Academy of Family Physicians 1
• Paroxetine is more anticholinergic than other SSRIs, which contributes to its sedating properties, as noted by the American Academy of Family Physicians 1
• Paroxetine is described as "less activating" in clinical guidelines, as stated by the American Academy of Family Physicians 1
• Citalopram is associated with sleep disturbances and somnolence, according to the American Academy of Family Physicians 1
• Some patients experience nausea and sleep disturbances with citalopram, as reported by the American Academy of Family Physicians 1
• Fluoxetine is described as "activating" in clinical guidelines, as stated by the American Academy of Family Physicians 1
• Fluoxetine has a very long half-life and active metabolite, which can impact its sedating properties, although the exact half-life is not provided in this context 1
• Sertraline is generally well-tolerated with less sedation, according to the American Academy of Family Physicians 1

Patient-Specific Considerations

• Consider paroxetine for patients with anxiety and insomnia, as recommended by the American Academy of Family Physicians 1
• Consider fluoxetine or sertraline for patients with depression and fatigue or psychomotor retardation, as suggested by the American Heart Association 2
• Consider sertraline for elderly patients at risk for falls, as recommended by the American Heart Association 2
• Consider sertraline for patients with cardiovascular disease, as it has been extensively studied and appears to have a lower risk of QTc prolongation, according to the American Heart Association 2
• Anxiolytics and sedating antidepressants significantly increase fall risk, especially when combined with cardiovascular medications, as warned by the American Heart Association 2
• Sertraline has a safer cardiac profile compared to other SSRIs, making it a suitable option for patients with cardiovascular disease, as stated by the American Heart Association 2
• For patients with insomnia and anxiety, consider paroxetine taken at bedtime, as suggested by the American Academy of Family Physicians 1
• For patients with fatigue or daytime drowsiness, consider fluoxetine taken in the morning, as recommended by the American Academy of Family Physicians 1
• For patients with cardiovascular disease, consider sertraline due to its safer cardiac profile, as recommended by the American Heart Association 2
• For elderly patients, avoid paroxetine due to anticholinergic effects and fall risk, and consider sertraline instead, as advised by the American Heart Association 2